Thus, BC cell lines overexpressing HER2 have higher levels of ACC compared to cell lines with lower HER2 expression, and the latter induce ACC expression upon exogenous HER2 stimulation, seemingly regulated through the PI3K/Akt/mTOR pathway [158]. The gene discussed is AKT1; the disease is adrenal cortex carcinoma.